Dr. Paul D. Lyons, MD PHD
Neurology (Clinical Neurophysiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 718
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of Alabama School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Neurophysiology Physician primary
VA license 0101231940 -
Neurodevelopmental Disabilities Physician
VA license 0101231940 -
Neurology Physician
VA license 0101231940 -
Sleep Medicine (Psychiatry & Neurology) Physician
VA license 0101231940
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Winchester Medical Center Winchester, VA
- Warren Memorial Hospital Front Royal, VA
- Shenandoah Memorial Hospital Woodstock, VA
- Hampshire Memorial Hospital Romney, WV
- Valley Health War Memorial Hospital Berkeley Springs, WV
Medical groups
- Winchester Medical Center (317 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 718
- Services billed
- 3,104
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in arm or leg muscles, complete study | 392 | 217 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 145 | 95 |
| Nerve conduction, 7-8 studies | 138 | 137 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 123 | 59 |
| Measurement of brain wave activity (eeg), awake and drowsy | 103 | 101 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 66 | 64 |
| Ct scan of blood vessels of head with contrast | 60 | 60 |
| Ct scan of blood vessels of neck with contrast | 58 | 58 |
| Nerve conduction, 13 or more studies | 56 | 56 |
| New patient office or other outpatient visit, 60-74 minutes | 45 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levetiracetam Other prescribers in Winchester, VA | 108 |
| Epidiolex (cannabidiol (cbd)) | 93 |
| Lamotrigine Other prescribers in Winchester, VA | 61 |
| Donepezil Hcl Other prescribers in Winchester, VA | 61 |
| Topiramate Other prescribers in Winchester, VA | 46 |
| Xcopri (cenobamate) | 39 |
| Divalproex Sodium Other prescribers in Winchester, VA | 23 |
| Memantine Hcl Other prescribers in Winchester, VA | 22 |
| Botox (onabotulinumtoxina) | 22 |
| Lamictal (lamotrigine) Other prescribers in Winchester, VA | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 36 companies reported 152 payments worth $15,100 in total to this clinician.
| UCB, Inc. | $10,335 |
|---|---|
| Jazz Pharmaceuticals Inc. | $1,764 |
| Sk Life Science, Inc. | $339 |
| Neurelis, Inc. | $261 |
| Eisai Inc. | $192 |
| Pfizer Inc. | $180 |
| Lilly USA, LLC | $169 |
| AbbVie Inc. | $165 |
| Compensation for services other than consulting (speaking, faculty) | $10,270 |
|---|---|
| Food and Beverage | $3,990 |
| Consulting Fee | $840 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) Fintepla · Neurology | $3,400 |
| UCB, Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) Fintepla · Neurology | $3,400 |
| Jazz Pharmaceuticals Inc. Apr 30, 2025 | Compensation for services other than consulting (speaking, faculty) EPIDIOLEX · NEUROLOGY | $1,470 |
| UCB, Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) Fintepla · Neurology | $1,000 |
| UCB, Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) Fintepla · Neurology | $1,000 |
| UCB, Inc. May 23, 2025 | Consulting Fee Fintepla · Neurology | $840 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 4 companies. The companies reported $85,423 in research payments for these studies, mostly to the institutions running them.
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC - YKP3089C049
Sk Life Science, Inc. - A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
UCB SA · Enrolling by invitation · NCT05076617 - A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals Inc. - A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
UCB SA · Recruiting · NCT05077904
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.